| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.46B | — | -3.5% |
| Cost of Revenue | $677.0M | — | +0.7% |
| Gross Profit | $783.0M | — | -6.9% |
| R&D Expense | $93.0M | — | -3.1% |
| SG&A Expense | $424.0M | — | +1.0% |
| Interest Expense | $111.0M | — | -10.5% |
| Pre-tax Income | $213.0M | — | +110.9% |
| Income Tax | $67.0M | — | +378.6% |
| Net Income | $146.0M | — | +67.8% |
| EPS (Basic) | $0.56 | — | +64.7% |
| EPS (Diluted) | $0.55 | — | +66.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.12B | +94.4% | +104.0% |
| Accounts Receivable | $1.38B | +4.0% | -5.0% |
| Inventory | $1.37B | -2.3% | +0.8% |
| Current Assets | $4.93B | +13.3% | +12.8% |
| Total Assets | $13.00B | +1.0% | -1.2% |
| Current Liabilities | $2.50B | +4.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $225.0M | — | +200.0% |
| Capital Expenditures | $37.0M | — | +15.6% |
| Investing Cash Flow | $386.0M | — | +324.4% |
| Financing Cash Flow | -$38.0M | — | +49.3% |
| Free Cash Flow | $188.0M | — | +337.2% |
| -4.4% |
| Long-term Debt | $8.57B | -0.9% | -4.3% |
| Total Liabilities | $12.09B | -0.2% | -4.1% |
| Stockholders' Equity | $903.0M | +20.1% | +66.6% |